Walgreens is launching Walgreens Specialty Pharmacy, a $24 billion business that will integrate new gene and cell services with existing pharmacy assets, including AllianceRx. The move will enhance Walgreens’ healthcare services and solidify its position as the largest independent provider of specialty pharmacy services.